Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04984863
Other study ID # RuijinH20190228
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date June 30, 2022

Study information

Verified date January 2021
Source Ruijin Hospital
Contact Duowu Zou, M.D.
Phone +86-13901617608
Email zdw12125@rjh.com.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study proposed for the first time the use of MCE to evaluate the efficacy of the treatment of gastroesophageal varices, and compared the examination results with the gold standard to explore whether MCE could replace the electronic gastroscopy as the preferred non-invasive evaluation method for the treatment of gastroesophageal varices.


Description:

Gastro-esophageal varices is one of the complications of portal hypertension in cirrhosis. For patients with moderate to severe varicose veins, international guidelines recommend active treatment, including endoscopic therapy such as endoscopic band ligation (EBL) and interventional radiotherapy such as balloon-occluded retrograde transvenous obliteration (B-RTO)Electronic gastroscopy is the gold standard for the diagnosis of varicose veins at higher blood risk (varicose veins requiring retreatment). However, it is relatively invasive and uncomfortable in the examination process, so that patients with gain-and-compensation cirrhosis are often unwilling to accept it, which is not conducive to the standardized follow-up after the treatment of gastro-esophageal varices.Magnetically controlled capsule endoscopy (MCE) is a non-invasive detection method independently developed in China that covers the whole digestive tract (except colon) mucosa. Patients only need to swallow a capsule endoscope to make repeated observation for many times, and the examination process is painless. It is an ideal method for diagnosing varicose veins with high blood risk (varicose veins that need treatment). Therefore, this study proposed for the first time the use of MCE to evaluate the efficacy of the treatment of gastroesophageal varices, and compared the examination results with the gold standard to explore whether MCE could replace the electronic gastroscopy as the preferred non-invasive evaluation method for the treatment of gastroesophageal varices.


Recruitment information / eligibility

Status Recruiting
Enrollment 96
Est. completion date June 30, 2022
Est. primary completion date January 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - 18-75 years old - Confirmed cirrhosis by clinical or pathological biopsy - Previous endoscopic treatment of esophageal and gastric varices, including but not limited to sclerotherapy, injection of tissue adhesives, skin entrapment, etc - Electronic gastroscopy is to be performed - Voluntary informed consent Exclusion Criteria: Absolute contraindications: - Patients without surgical conditions or refusing any abdominal surgery (once the capsule is stranded, it cannot be removed by surgery) - There is a pacemaker in the body, except that the pacemaker is a new MRI compatible product - Electronic devices such as cochlear implants, magnetic metal drug infusion pumps, nerve stimulators and magnetic metal foreign bodies are implanted in the body; - .Women during pregnancy Relative contraindication: - Gastrointestinal obstruction, stenosis, and fistula are known or suspected - Dysphagia

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Magnetically controlled capsule endoscopy
Magnetically controlled capsule endoscopy (MCE) is a non-invasive detection method independently developed in China that covers the whole digestive tract (except colon) mucosa.

Locations

Country Name City State
China Ruijin Hospital Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Ruijin Hospital

Country where clinical trial is conducted

China, 

References & Publications (6)

Cremers I, Ribeiro S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol. 2014 Sep;7(5):206-16. doi: 10.1177/1756283X14538688. Review. — View Citation

de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. — View Citation

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018 — View Citation

Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017 Jan;65(1):31 — View Citation

Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R; Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhos — View Citation

Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, Attili AF, Riggio O. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003 Mar;38(3):266-72. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluating the clinical usefulness of MCE in assessing the efficacy of gastro-oesophageal varices treated under gastroscopy. Comparing the value of MCE and gastroscopy in the grading of esophagogastric varices 15-30 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT04867954 - Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
Not yet recruiting NCT04525768 - Gastroesophageal Varices in Cavernoma
Not yet recruiting NCT04527666 - Anticoagulation in Gastroesophageal Varices and JAK2 Mutation
Not yet recruiting NCT03729921 - Gastric Variceal Ligation Versus Gastric Variceal Obturation for Secondary Prophylaxis of Gastric Varices N/A
Not yet recruiting NCT04543643 - Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis Phase 3
Terminated NCT03910413 - Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices N/A
Recruiting NCT04692805 - EUS-guided PSE in Combination With EUS-guided Treatment of Varices for Patients With Portal Hypertension N/A
Recruiting NCT02646202 - Scleroligation for Eradication of Gastroesophageal Varices. Phase 3
Recruiting NCT04640350 - Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
Recruiting NCT04639323 - Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)
Recruiting NCT02638415 - The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric Varices Phase 4
Not yet recruiting NCT04524650 - Early Diagnosis of Oxaliplatin-induced Portal Hypertension
Recruiting NCT04123509 - Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis
Completed NCT02672319 - EUS-guided Glue Injection for Varices Study N/A
Recruiting NCT04786743 - Timing of Endoscopic Intervention for Acute Variceal Hemorrhage: an RCT N/A